Por: The New York Times Health October 20, 2022
A Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm births.Makena has been in use for 11 years, and the panel’s vote was widely of the agency’s “accelerated approval” program, which has expedited nearly 300 promising drugs to the market in 30 years. The program has been criticized for leaving... + full article
The Boston Globe USA Nation October 20, 2022
A Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm birth.Makena has been in use for 11 years, and the panel’s vote was widely... + más
F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market | The New York Times
FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC
Los Angeles Times USA Science October 20, 2022
A federal advisory panel voted Wednesday to recommend that the only approved drug to prevent premature birth be removed from pharmacy shelves because studies have shown it does not work. The 14-to-1 vote came more than a decade after the Food and Drug Administration approved the... + más
FDA panel backs removal of unproven pregnancy drug | Portland Press Herald
WPLG Local 10 USA Health October 19, 2022
WASHINGTON – Federal health advisers have concluded that a drug intended to prevent premature births hasn't been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market.The Food and Drug Administration’s... + más
FDA panel backs removal of unproven pregnancy drug | 10 WBNS
FDA panel backs removal of unproven pregnancy drug | ABC News
CNBC USA Health October 19, 2022
An advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works.The recommendation, in a 14-1 vote, from the agency's Obstetrics, Reproductive and... + más
FDA panel backs removal of unproven pregnancy drug | WPLG Local 10
ALS drug wins FDA approval despite questionable data | ABC News
10 WBNS USA Health October 19, 2022
WASHINGTON — Federal health advisers ruled Wednesday that a drug intended to prevent premature births doesn’t work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market. The Food and Drug Administration’s advisory panel... + más
ABC News USA Health October 19, 2022
WASHINGTON -- Federal advisers have concluded that a drug intended to prevent premature births hasn't been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market.The Food and Drug Administration’s advisory... + más
Portland Press Herald USA Health October 19, 2022
WASHINGTON — Federal health advisers have concluded that a drug intended to prevent premature births hasn’t been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market. A panel of federal advisers says Makena,... + más
About iurex | Privacy Policy | Disclaimer |